NASDAQ:DRIO - Nasdaq - US23725P2092 - Common Stock - Currency: USD
Overall DRIO gets a fundamental rating of 3 out of 10. We evaluated DRIO against 37 industry peers in the Health Care Technology industry. DRIO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. DRIO shows excellent growth, but is valued quite expensive already.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -34.47% | ||
ROE | -56.9% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 49.06% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.33 | ||
Debt/FCF | N/A | ||
Altman-Z | -5.32 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 2.44 | ||
Quick Ratio | 2.15 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:DRIO (5/2/2025, 9:44:15 PM)
0.75
+0.03 (+3.79%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 1.15 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 0.43 | ||
P/tB | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -34.47% | ||
ROE | -56.9% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 49.06% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.33 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 1.86% | ||
Cap/Sales | 0.51% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 2.44 | ||
Quick Ratio | 2.15 | ||
Altman-Z | -5.32 |